Western Blotting Protocol

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

Western blotting detects a specific protein in a complex mixture through antibody recognition after gel electrophoresis and membrane transfer.
Begin with validated antibodies and appropriate controls, then optimize blocking, washing, and detection steps for reproducible results.
Quantification requires normalization to a loading control and careful attention to linear detection range, which limits direct comparisons across experiments.

At a Glance

Step	Purpose	Key Decision	Common Error
Sample preparation	Extract proteins in a buffer compatible with downstream analysis	Choose lysis buffer based on protein solubility and downstream compatibility	Using too much or too little sample, leading to inconsistent loading
Gel electrophoresis	Separate proteins by molecular weight	Select gel percentage based on target protein size	Loading unequal protein amounts across wells
Transfer	Move proteins from gel to membrane	Choose transfer method and membrane based on protein size and charge	Incomplete transfer, especially for large or hydrophobic proteins
Blocking	Prevent nonspecific antibody binding	Use blocking buffer that minimizes background without masking signal	Over-blocking, which can reduce specific signal
Primary antibody incubation	Bind antibody specifically to target protein	Optimize antibody concentration and incubation time	Use too high or too low antibody concentration
Secondary antibody incubation	Detect the primary antibody	Choose an appropriate enzyme or fluorophore conjugate	Cross-reactivity with other species antibodies
Detection	Visualize the target protein	Use a detection method with a linear range for quantification	Signal saturation or high background
Quantification	Measure relative protein expression	Normalize to a loading control and use linear range	Compare signals outside the linear range

Introduction to Western Blotting

Western blotting is a laboratory technique used to detect a specific protein within a complex mixture extracted from cells or tissue. The method combines protein separation by size with antibody-based detection to identify and quantify target proteins. Researchers use this technique to measure relative protein expression, confirm protein identity, and study post-translational modifications.

The workflow begins with protein extraction and quantification, followed by gel electrophoresis to separate proteins by molecular weight. Proteins are then transferred to a membrane, where they are probed with antibodies that bind specifically to the target protein. Detection reagents produce a signal that corresponds to the amount of protein present.

The technique is widely used in molecular biology and laboratory medicine. It is a standard method for validating protein expression in experimental systems and for comparing protein levels across different conditions. The method requires careful planning, validated reagents, and consistent technique to produce reliable results.

Core Principles of Western Blotting

Protein Separation by Electrophoresis

Proteins are separated by size using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). SDS denatures proteins and gives them a uniform negative charge proportional to their mass. When an electric current is applied, proteins migrate through the polyacrylamide gel matrix at a rate that depends on their molecular weight. Smaller proteins move faster and travel farther than larger proteins.

The gel percentage determines the range of protein sizes that can be resolved. A higher percentage gel provides better resolution for small proteins, while a lower percentage gel is better for large proteins. The choice of gel percentage depends on the size of the target protein and the range of proteins in the sample.

Transfer to a Membrane

After separation, proteins are transferred from the gel to a membrane, typically made of nitrocellulose or polyvinylidene fluoride (PVDF). The transfer is achieved by applying an electric field perpendicular to the gel, which moves the proteins out of the gel and onto the membrane. The membrane binds proteins through hydrophobic interactions, preserving the separation pattern.

The efficiency of transfer depends on the protein size, the membrane type, and the transfer conditions. Large proteins transfer more slowly and may require longer transfer times or a different transfer buffer. PVDF membranes have a higher protein-binding capacity than nitrocellulose, but they require activation in methanol before use.

Antibody Detection

The membrane is then incubated with a primary antibody that specifically binds to the target protein. After washing to remove unbound antibody, the membrane is incubated with a secondary antibody that recognizes the primary antibody. The secondary antibody is conjugated to an enzyme or fluorophore that produces a detectable signal.

The signal is detected using a substrate that produces a colored or chemiluminescent product. The intensity of the signal is proportional to the amount of target protein on the membrane. The signal can be captured on film or with a digital imaging system for quantification.

Practical Workflow

Sample Preparation and Protein Purification

The first step in a Western blot is to prepare a protein extract from the sample of interest. Cells or tissues are lysed using a buffer that disrupts cell membranes and releases proteins. The lysis buffer typically contains a detergent, a salt, and a pH buffer to maintain protein stability. Protease inhibitors are often added to prevent protein degradation during the extraction process.

The protein concentration of the lysate is measured using a protein quantification assay, such as the Bradford or BCA assay. Accurate protein quantification is critical for loading equal amounts of protein in each well of the gel. Unequal loading can lead to false differences in protein expression.

The choice of lysis buffer depends on the downstream application. For example, if the target protein is a membrane protein, a buffer containing a stronger detergent may be needed to solubilize the protein. If the target protein is phosphorylated, a buffer containing a phosphate inhibitor may be needed to preserve the phosphorylation state.

Gel Electrophoresis

The protein samples are mixed with a loading buffer that contains SDS and a tracking dye. The samples are heated to denature the proteins and ensure they are fully coated with SDS. The samples are then loaded into the wells of a polyacrylamide gel.

The gel is placed in an electrophoresis chamber filled with a running buffer. An electric current is applied, and the proteins migrate through the gel. The tracking dye indicates the progress of the electrophoresis. The gel is run until the dye front reaches the bottom of the gel.

The gel percentage is chosen based on the size of the target protein. A 10% gel is suitable for proteins in the range of 20 to 80 kDa, while a 12% gel is better for smaller proteins. A 6% gel is used for larger proteins above 100 kDa.

Transfer to Membrane

After the gel is run, the proteins are transferred to a membrane. The gel is placed in contact with the membrane, and the sandwich is placed in a transfer apparatus. The transfer is performed in a buffer that facilitates the movement of proteins from the gel to the membrane.

The transfer time and voltage depend on the protein size and the transfer method. A wet transfer is performed at a constant voltage for a set time, while a semi-dry transfer is faster but may be less efficient for large proteins. The transfer efficiency can be checked by staining the membrane with a reversible stain, such as Ponceau S, to confirm that proteins have been transferred.

Blocking and Antibody Incubation

The membrane is incubated with a blocking buffer to prevent nonspecific binding of antibodies. The blocking buffer contains a protein, such as bovine serum albumin (BSA) or non-fat dry milk, that binds to the membrane and blocks the sites where antibodies could bind nonspecifically.

The membrane is then incubated with the primary antibody. The antibody is diluted in a buffer that is compatible with the antibody and the blocking agent. The incubation time and temperature depend on the antibody and the target protein. Some antibodies require an overnight incubation at 4 degrees Celsius, while others can be incubated for one hour at room temperature.

After the primary antibody incubation, the membrane is washed to remove unbound antibody. The membrane is then incubated with the secondary antibody, which is conjugated to an enzyme or a fluorophore. The secondary antibody is diluted in a buffer that is compatible with the detection method.

Detection and Imaging

The membrane is incubated with a substrate that produces a signal in the presence of the enzyme conjugated to the secondary antibody. The signal can be a colorimetric, chemiluminescent, or fluorescent signal. The signal is captured using a film or a digital imaging system.

The intensity of the signal is proportional to the amount of target protein on the membrane. The signal can be quantified using image analysis software. The signal intensity is normalized to a loading control, such as a housekeeping protein, to correct for differences in protein loading.

Quantitative Analysis and Normalization

Loading Controls

A loading control is a protein that is expressed at a constant level across all samples. The loading control is used to normalize the signal of the target protein to account for differences in protein loading and transfer efficiency. Common loading controls include beta-actin, GAPDH, and tubulin.

The loading control should be chosen based on the experimental system and the target protein. The loading control should not be affected by the experimental treatment. The loading control should be detected on the same membrane as the target protein, or on a separate membrane that is run in parallel.

Normalization Strategy

The signal intensity of the target protein is divided by the signal intensity of the loading control to obtain a normalized value. The normalized values are compared across samples to measure relative protein expression. The normalization corrects for differences in protein loading and transfer efficiency.

The normalization strategy should be validated for each experiment. The loading control should be in the linear range of detection. The signal intensity of the loading control should be similar across all samples. If the loading control signal varies significantly, the normalization may be unreliable.

Linear Detection Range

The detection system has a linear range, which is the range of signal intensities that are proportional to the amount of protein. The signal intensity should be within the linear range for accurate quantification. If the signal is too high, the signal may be saturated, and the quantification will be inaccurate. If the signal is too low, the signal may be below the limit of detection.

The linear range can be determined by loading a dilution series of a known protein and measuring the signal intensity. The signal intensity should be proportional to the amount of protein within the linear range. The linear range depends on the detection method and the antibody.

Controls and Validation

Positive and Negative Controls

A positive control is a sample that is known to contain the target protein. The positive control confirms that the antibody detects the target protein and that the detection system is working. A negative control is a sample that is known to lack the target protein. The negative control confirms that the antibody does not bind to other proteins in the sample.

The controls should be included in every experiment. The positive control should produce a signal at the expected molecular weight. The negative control should produce no signal or a signal that is not at the expected molecular weight.

Antibody Validation

Antibody validation is essential for reliable Western blot results. The antibody should be tested to confirm that it binds specifically to the target protein and does not cross-react with other proteins. The antibody should be tested using a sample that is known to express the target protein and a sample that is known to lack the target protein.

The antibody should be tested at different concentrations to determine the optimal concentration. The antibody should be tested using a dilution series of the target protein to confirm that the signal is proportional to the amount of protein. The antibody should be tested using a sample that has been treated to knock down or knock out the target protein to confirm the specificity.

Reproducibility

Reproducibility is the ability to obtain the same results when the experiment is repeated. Reproducibility is affected by the quality of the reagents, the consistency of the protocol, and the skill of the researcher. The experiment should be repeated at least three times to confirm the results.

The results should be consistent across the replicates. The normalized intensity of the target protein should be similar across the replicates. The variability between the replicates should be reported as the standard deviation or the standard error of the mean.

Common Failure Patterns

High Background

High background is a common problem in Western blotting. The background is the signal that is not specific to the target protein. The background can be caused by nonspecific binding of the antibody, insufficient blocking, or the detection of the antibody.

The background can be reduced by increasing the blocking time, using a different blocking buffer, or reducing the antibody concentration. The background can also be reduced by washing the membrane more thoroughly or by using a different detection method.

No Signal

No signal is a common problem when the target protein is not detected. The signal can be absent if the target protein is not present in the sample, if the antibody does not bind to the target protein, or if the detection system is not working.

The signal can be restored by confirming that the target protein is present in the sample, by using a different antibody, or by optimizing the detection system. The signal can be restored by increasing the amount of protein loaded, by increasing the antibody concentration, or by using a more sensitive detection method.

Multiple Bands

Multiple bands are a common problem when the antibody binds to proteins other than the target protein. The bands can be caused by cross-reactivity, degradation of the target protein, or the presence of protein isoforms.

The bands can be addressed by using a more specific antibody, by optimizing the sample preparation to prevent degradation, or by using a different gel percentage to resolve the bands. The bands can be addressed by using a different blocking buffer or by reducing the antibody concentration.

Safety and Regulatory Context

Biosafety Considerations

Western blotting involves the use of chemicals and biological samples that may be hazardous. The chemicals used in the lysis buffer, the gel, and the detection system may be toxic or corrosive. The biological samples may contain infectious agents.

The biosafety principles should be followed when working with biological samples. The risk assessment should be performed before the experiment. The work should be performed in a biosafety cabinet if the sample is infectious. The waste should be disposed of according to the institutional guidelines.

The Biosafety in Microbiological and Biomedical Laboratories provides guidance on the biosafety principles, risk assessment, and containment. The institutional biosafety committee should be consulted for the risk assessment and the containment of the biological samples.

Recombinant and Synthetic Nucleic Acid Molecules

If the Western blot is used to detect a protein that is expressed from a recombinant or synthetic nucleic acid molecule, the work may be subject to the NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. The guidelines provide the oversight for the research that involves the recombinant or synthetic nucleic acid molecules.

The institutional biosafety committee should be consulted for the work that involves the recombinant or synthetic nucleic acid molecules. The work should be performed according to the guidelines and the institutional policies.

Quality and Measurement Science

The quality of the Western blot results depends on the quality of the reagents and the measurement. The measurement of the protein concentration and the signal intensity should be performed using calibrated instruments. The NIST Laboratory Programs provides the measurement science and the standards for the calibration of the instruments.

The protein quantification assay should be validated to ensure that the measurement is accurate. The signal intensity should be measured using a calibrated imaging system. The measurement should be performed in a consistent manner across the experiments.

Practical Implementation and Assessment

Step-by-Step Implementation

Prepare the protein sample by lysing the cells or tissue in a lysis buffer that contains a protease inhibitor.
Measure the protein concentration using a protein quantification assay.
Load the protein samples into the wells of a polyacrylamide gel.
Run the gel to separate the proteins by size.
Transfer the proteins from the gel to the membrane.
Block the membrane to prevent nonspecific binding.
Incubate the membrane with the primary antibody.
Wash the membrane to remove unbound antibody.
Incubate the membrane with the secondary antibody.
Wash the membrane to remove unbound antibody.
Detect the signal using a substrate or a fluorophore.
Capture the signal using a digital imaging system.
Quantify the signal using image analysis software.
Normalize the signal to a loading control.

Assessment of the Results

The results of the Western blot should be assessed for the quality of the signal and the specificity of the antibody. The signal should be at the expected molecular weight. The signal should be absent in the negative control. The signal should be present in the positive control.

The signal should be within the linear range of the detection system. The signal should be normalized to the loading control. The normalized signal should be compared across the conditions.

Records and Measurements

The records of the Western blot should include the following information:

The date of the experiment
The sample preparation and the lysis buffer
The protein concentration and the quantification assay
The gel percentage and the electrophoresis conditions
The transfer method and the transfer conditions
The blocking buffer and the blocking time
The primary antibody and the antibody concentration
The secondary antibody and the antibody concentration
The detection method and the detection conditions
The image of the membrane
The signal intensity and the normalized signal

The records should be maintained for the reproducibility of the experiment. The records should be reviewed for the quality of the results.

Limitations and Professional Escalation

Limitations of the Western Blot

The Western blot is a semi-quantitative method. The signal intensity is proportional to the amount of protein, but the relationship is not linear across the entire range. The quantification is relative, and the results are compared across the conditions.

The Western blot is not a high-throughput method. The method is time-consuming and requires a significant amount of manual labor. The method is not suitable for the analysis of a large number of samples.

The Western blot is not a sensitive method for the detection of low-abundance proteins. The method requires a large amount of protein to detect the target protein. The method is not suitable for the detection of proteins that are present at a low concentration.

Professional Escalation

The results of the Western blot should be escalated to a professional if the results are inconsistent or if the results are not reproducible. The professional should be consulted if the antibody is not validated or if the detection system is not working.

The professional should be consulted if the results are not within the linear range or if the normalization is not appropriate. The professional should be consulted if the results are not consistent with the expected results.

Decision Framework for Antibody Selection and Validation

Antibody selection is the single most consequential decision in a Western blot workflow. A poorly chosen antibody produces misleading bands, wasted reagents, and unreproducible data regardless of how carefully the remaining steps are executed. This section provides a structured decision framework for selecting, validating, and documenting antibodies so that the resulting blots support defensible quantitative conclusions.

Tiered Antibody Validation Approach

Antibody validation should follow a tiered approach that matches the intended use of the data. A screening experiment designed to ask whether a protein is present requires less validation than a quantitative comparison of expression levels across treatment groups. The tiered framework below assigns validation depth to experimental purpose.

Tier 1: Presence or absence screening. This tier applies when you only need to know whether a protein is detectable in a sample. Validation requires a positive control that is known to express the target and a negative control that is known to lack it. The negative control can be a knockout cell line, a knockdown sample, or a tissue that does not express the target. The antibody must produce a band at the expected molecular weight in the positive control and no band at that molecular weight in the negative control. If the negative control shows a band at the expected molecular weight, the antibody is not specific enough for even Tier 1 use.

Tier 2: Relative quantification across conditions. This tier applies when you compare target protein levels between treated and untreated samples or across a time course. In addition to the Tier 1 controls, you must demonstrate that the signal is proportional to the amount of protein loaded. This requires a dilution series of one representative sample. Load two-fold serial dilutions of the sample and confirm that the signal intensity increases proportionally across at least three dilution points. If the signal does not change with the dilution, the antibody concentration is saturating or the detection system is saturated. The dilution series also establishes the linear range for the specific antibody and sample combination.

Tier 3: Quantitative comparison across many samples. This tier applies to experiments that compare protein levels across multiple biological replicates or across a panel of cell lines. In addition to the Tier 2 requirements, you must confirm that the loading control signal is stable across all samples and that the target protein signal falls within the linear range for every sample. You must also document the antibody lot number and the passage number of the cells used for validation. Lot-to-lot variation in antibody performance is common, and a new lot should be revalidated before use in quantitative experiments.

The Addgene Protocols collection provides educational context for antibody handling and storage, but it does not replace validation against your specific sample type. Antibodies that work well in one cell line may perform poorly in another due to differences in protein abundance, post-translational modifications, or the presence of cross-reactive proteins.

Antibody Decision Matrix

The following decision matrix guides the selection of a primary antibody for a new target protein. The matrix is designed to be used before you purchase or borrow an antibody.

Decision Point	Question to Answer	Action if Yes	Action if No
Published validation	Has the antibody been validated for Western blot in your species and sample type?	Review the validation data and confirm the expected band size	Search for an alternative antibody or plan your own validation
Knockout or knockdown data	Has the antibody been tested in a knockout or knockdown system?	Confirm the band disappears or is reduced in the knockout sample	Plan a knockdown or knockout validation experiment
Species reactivity	Does the antibody recognize the species of your sample?	Proceed to the next decision point	Select a different antibody or use a cross-reactive antibody with caution
Recommended dilution	Does the manufacturer provide a recommended dilution for Western blot?	Use the recommended dilution as a starting point	Use a dilution series to determine the optimal concentration
Lot consistency	Is the antibody available from a stable supply with lot documentation	Record the lot number and reorder the same lot for the experiment	Plan for revalidation when the lot changes

The decision matrix is a planning tool. It does not replace the need for empirical validation in your own hands. The National Library of Medicine gateway provides access to laboratory-method references that describe antibody validation approaches in detail.

Transfer Method Decision Framework

The transfer step determines whether the proteins that were separated by size are available for antibody detection. An incomplete transfer produces a weak or absent signal for the target protein even when the antibody is excellent. The transfer method must be matched to the molecular weight of the target protein and the gel percentage used for separation.

Wet transfer is the most reliable method for proteins across a wide molecular weight range. The gel and membrane are submerged in transfer buffer, and the transfer is performed at a constant voltage for a defined time. Wet transfer is the preferred method for proteins above 100 kDa because the buffer volume provides a larger reservoir that prevents the gel from drying out during the transfer. The transfer time for a wet transfer is typically 60 to 120 minutes at a constant voltage of 100 volts. The transfer time should be adjusted based on the protein size and the gel percentage.

Semi-dry transfer is faster than wet transfer and uses less buffer. The gel and membrane are placed between filter papers that are soaked in transfer buffer, and the transfer is performed at a constant current for 15 to 30 minutes. Semi-dry transfer is suitable for proteins in the range of 20 to 100 kDa. The method is less efficient for large proteins because the limited buffer volume can lead to incomplete transfer. Semi-dry transfer is also more sensitive to the thickness of the gel and the quality of the filter papers.

Turbid transfer is a variant that uses a higher current and a shorter time. This method is not recommended for quantitative work because the transfer efficiency is less reproducible than wet or semi-dry transfer.

The transfer method decision should be based on the target protein size and the downstream quantification requirement. If the target protein is above 100 kDa, use a wet transfer. If the target protein is below 100 kDa and you need a fast transfer, use a semi-dry transfer. If the target protein is below 20 kDa, use a wet transfer with a membrane that has a small pore size to prevent the protein from passing through the membrane.

Transfer Efficiency Verification

Transfer efficiency should be verified before antibody incubation. A reversible protein stain such as Ponceau S provides a quick check that proteins were transferred to the membrane. The stain produces a red signal that binds to the protein bands. The stain is washed away before the blocking step.

The Ponceau S stain confirms that proteins are present on the membrane, but it does not confirm that the target protein was transferred. A more specific check is to probe the membrane with an antibody against a protein that is known to be abundant in the sample. If the abundant protein is detected, the transfer worked for that protein. The absence of the target protein signal may indicate that the target protein was not transferred or that the antibody does not recognize the target.

The transfer efficiency can also be checked by staining the gel after transfer. The gel is stained with Coomassie Blue to detect the proteins that remain in the gel. If a large amount of protein remains in the gel, the transfer was incomplete. The transfer time should be increased or the transfer method should be changed.

Record System for Antibody and Transfer Decisions

A record system for antibody and transfer decisions is essential for reproducibility. The records should be maintained in a laboratory notebook or an electronic system that is accessible to the research team. The records should include the following information for each antibody:

The antibody name and the catalog number
The lot number and the expiration date
The species and the isotype
The recommended dilution and the dilution used
The blocking buffer and the blocking time
The incubation time and the temperature
The detection method and the substrate
The validation data that was used to confirm the specificity

The records for the transfer should include the following information:

The transfer method (wet or semi-dry)
The transfer buffer and the buffer composition
The transfer time and the voltage or current
The membrane type and the pore size
The gel percentage and the gel thickness
The Ponceau S image or the transfer verification result

The records should be reviewed before the experiment is repeated. If the antibody lot changes, the new lot should be validated before the experiment is repeated. If the transfer conditions change, the transfer efficiency should be verified before the experiment is repeated.

Common Failure Patterns in Antibody Selection and Transfer

Failure pattern: The antibody produces a band at the wrong molecular weight

This pattern indicates that the antibody is binding to a protein other than the target. The band may be a degradation product, a cross-reactive protein, or a nonspecific band. The first step is to check the expected molecular weight of the target protein and the molecular weight of the band. If the band is at a different size, the antibody may not be specific. The antibody should be tested against a knockout or knockdown sample to confirm the specificity.

Failure pattern: The antibody produces a high background signal.

The high background can be caused by the antibody concentration being too high, the blocking buffer being insufficient, or the detection system being too sensitive. The antibody concentration should be reduced, the blocking time should be increased, or the detection substrate should be diluted. The background can also be caused by the secondary antibody binding to the primary antibody that is bound to the membrane.

Failure pattern: The target protein is not detected.

The target protein may not be present in the sample, the antibody may not recognize the target, or the transfer may have failed. The first step is to confirm that the target protein is present in the sample using a different method. The second step is to confirm that the antibody is working using a positive control. The third step is to confirm that the transfer worked using a Ponceau S stain.

Failure pattern: The signal is saturated.

The signal is saturated when the detection system is overloaded. The signal is no longer proportional to the amount of protein. The signal can be reduced by loading less protein, using a lower antibody concentration, or using a shorter detection time. The signal should be within the linear range for quantification.

Practical Implementation Steps for the Decision Framework

Define the experimental purpose and the required validation tier.
Use the antibody decision matrix to select a candidate antibody.
Obtain the antibody and record the lot number and the catalog number.
Perform a dilution series to determine the optimal antibody concentration.
Test the antibody with a positive and a negative control.
Confirm the band is at the expected molecular weight.
Select the transfer method based on the target protein size.
Perform the transfer and verify the transfer efficiency with a Ponceau S stain.
Record the antibody and transfer conditions in the laboratory notebook.
Repeat the validation if the antibody lot or the transfer conditions change.

Assessment of the Decision Framework

The decision framework should be assessed after each experiment. The assessment should answer the following questions:

Did the antibody produce a single band at the expected molecular weight?
Did the negative control show no band at the expected molecular weight?
Did the signal increase proportionally with the protein amount?
Did the transfer produce a complete transfer of the proteins?
Did the Ponceau S stain show a consistent protein pattern across the samples?

If the answer to any of these questions is no, the experiment should be repeated with the appropriate adjustments. The adjustments should be recorded in the laboratory notebook.

Professional Escalation Criteria

The following situations require professional escalation:

The antibody produces a band at the wrong molecular weight and the knockout or knockdown validation does not resolve the issue.
The antibody produces a high background that cannot be reduced by changing the blocking buffer or the antibody concentration.
The target protein is not detected after the transfer and the positive control also fails to produce a signal.
The transfer efficiency is inconsistent across the samples and the transfer conditions cannot be adjusted to improve the efficiency.

In these situations, a senior researcher or a laboratory manager should be consulted. The professional can help to identify the cause of the problem and to select a different antibody or a different transfer method. The professional can also help to determine whether the experiment should be repeated or whether the data should be excluded from the analysis.

Measurement Science and Quality Context

The decision framework is aligned with the measurement science principles described in the NIST Laboratory Programs. The antibody validation and the transfer verification are quality control steps that ensure the measurement is accurate and reproducible. The record system provides the documentation that is needed for the measurement to be traced back to the original reagents and conditions.

The MIQE Guidelines provide a framework for reporting the controls and the transparency of the measurement. Although the MIQE guidelines were developed for qPCR, the principles of reporting the controls, the validation, and the conditions are applicable to Western blotting. The records should include the information that is needed for another researcher to repeat the experiment and to obtain the same results.

The NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules apply if the target protein is expressed from a recombinant or synthetic nucleic acid molecule. The institutional biosafety committee should be consulted for the oversight of the work. The biosafety principles in the Biosafety in Microbiological and Biomedical Laboratories should be followed when working with the biological samples.

Frequently Asked Questions

What is the purpose of the blocking step in a Western blot?

The blocking step prevents nonspecific binding of the antibody to the membrane. The blocking buffer contains a protein that binds to the membrane and blocks the sites where the antibody could bind nonspecific. The blocking step reduces the background signal and improves the specificity of the detection.

How do I choose the primary antibody for a Western blot?

The primary antibody should be validated for the target protein and the species of the sample. The antibody should be tested at different concentrations to determine the optimal concentration. The antibody should be tested using a positive and a negative control to confirm the specificity.

What is the linear range of the Western blot?

The linear range is the range of the signal that is proportional to the amount of protein. The signal should be within the linear range for accurate quantification. The linear range is determined by the detection method and the antibody concentration.

How do I normalize the Western blot signal?

The signal is normalized to a loading control, which is a protein that is expressed at a constant level across all samples. The signal of the target protein is divided by the signal of the loading control. The normalized signal is compared across the conditions.

What is the difference between a wet transfer and a semi-dry transfer?

A wet transfer is performed in a buffer that is filled with the transfer buffer. The transfer is performed at a constant voltage for a longer time. A semi-dry transfer is performed in a buffer that is soaked in the filter paper. The transfer is performed at a constant current for a shorter time.

What is the purpose of the molecular weight marker?

The molecular weight marker is a mixture of proteins of known molecular weight. The marker is used to estimate the size of the target protein. The marker is loaded into a separate well of the gel and is transferred to the membrane.

How can I reduce the background signal in a Western blot?

The background signal can be reduced by increasing the blocking time, using a different blocking buffer, or reducing the antibody concentration. The background can be reduced by washing the membrane more thoroughly or by using a different detection method.

What is the limit of the Western blot?

The Western blot is a semi-quantitative method. The method is not suitable for the detection of low-abundance proteins. The method is not suitable for the analysis of a large number of samples. The method is not suitable for the detection of proteins that are not recognized by the antibody.

Related Molecular Biology Guides

References and Further Reading

Molecular Biology and Laboratory Methods. National Library of Medicine.
Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
Addgene Protocols. Addgene.
MIQE Guidelines. Clinical Chemistry.
NIST Laboratory Programs. National Institute of Standards and Technology.
Western blotting (immunoblotting): history, theory, uses, protocol and problems.. BioTechniques, 2023.
Protein purification and analysis: next generation Western blotting techniques.. Expert review of proteomics, 2017.
Extracellular Vesicle Isolation and Analysis by Western Blotting.. Methods in molecular biology (Clifton, N.J.), 2017.
Western blotting: an introduction.. Methods in molecular biology (Clifton, N.J.), 2015.
Western blotting.. Methods (San Diego, Calif.), 2006.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.